Why is Tirzepatide more effective than Semaglutide GLP-1 for obesity management
As an FDA-registered 503B outsourcing facility and a 503A compounding pharmacy licensed in 49 states, Olympia specializes in compounding a plethora of medications ranging from IV nutrition and sexual health to mens and womens health, weight management, longevity and beyond all designed to help you deliver the best possible care to your patients
But between insurance coverage, copays, deductibles, and out-of-pocket costs, many patients struggle to understand what they'll actually pay and what they can afford
switch to a hydrophilic statin (rosuvastatin, pravastatin) if myalgias localize SGLT2 inhibitors: reinforce hydration targets (minimum 2.5 L daily) Laxatives or stimulant bowel preps: reduce frequency if already experiencing GLP-1-related diarrhea Tier 3: Low risk but worth documenting ACE inhibitors (can rarely cause cramps through unclear mechanisms) Beta-agonist inhalers (albuterol can lower serum potassium at high doses) The Endocrine Society's 2023 clinical practice guideline on pharmacologic management of obesity recommends monitoring electrolytes during the titration phase of anti-obesity medications, with particular attention to patients on concurrent diuretic therapy 9
From there, you can chat with a clinician about options like magnesium glycinate or non-hormonal prescription medications that target vasomotor symptoms like night sweats (such as Veozah or certain SSRIs/SNRIs)